1. Home
  2. GENI vs OCUL Comparison

GENI vs OCUL Comparison

Compare GENI & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genius Sports Limited

GENI

Genius Sports Limited

N/A

Current Price

$5.22

Market Cap

1.6B

ML Signal

N/A

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

N/A

Current Price

$5.60

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GENI
OCUL
Founded
2016
2006
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
GENI
OCUL
Price
$5.22
$5.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
12
Target Price
$10.24
★ $25.73
AVG Volume (30 Days)
★ 6.9M
2.5M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,990,000.00
Revenue This Year
$52.98
N/A
Revenue Next Year
$24.88
$79.15
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.48
52 Week Low
$3.83
$5.77
52 Week High
$11.58
$16.44

Technical Indicators

Market Signals
Indicator
GENI
OCUL
Relative Strength Index (RSI) 34.26 30.32
Support Level $4.00 N/A
Resistance Level $6.91 $7.64
Average True Range (ATR) 0.46 0.41
MACD -0.09 -0.04
Stochastic Oscillator 1.50 1.18

Price Performance

Historical Comparison
GENI
OCUL

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: